Psychological and psychiatric characterization of various groups of drugs users

被引:5
作者
Anghel, Daniela-Madalina Ciuca [1 ]
Anghel, Elena-Elisabeta [2 ]
Stan, Miriana [1 ,5 ]
Tudor, Gheorghe [3 ]
Dumitriu, Anca Silvia [4 ]
Paunica, Stana [4 ]
Baconi, Daniela Luiza [1 ]
机构
[1] Carol Davila Univ Med & Pharm, Dept Toxicol, Bucharest, Romania
[2] Ion Regnaga State Pedagogial Univ, Dept Special Sychol, Kishinev, Moldova
[3] Justinian Patriarhul Univ Theol, Dept Systmat Theology & Sacred Art, Bucharest, Romania
[4] Carol Davila Univ Med & Pharm, Dan Theodorescu Hosp, Bucharest, Romania
[5] Davila Univ Med & Pharm, Dept Toxicol, 37 Dionisie Lupu St, Bucharest 20021, Romania
关键词
new psychoactive substances; legal highs; personality changes; psychiatric; psychological; CANNABIS USE; CASE SERIES; RECEPTOR; ALCOHOL; INTOXICATION; INDIVIDUALS; AMPHETAMINE; TAMOXIFEN; IMPACT; SIDE;
D O I
10.22543/2392-7674.1356
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. We aimed to assess the differences among various groups of drugs users, especially in the psychiatric and psychological domains. Materials and Methods. A retrospective study was carried out in collaboration with C.E.T.T.T `St. Stelian` Institute from Bucharest. There were analyzed the medical records of 604 hospitalized patients with heroin or polydrug addiction. Results. Significant differences in diagnosis at submission among groups were outlined (personality and behavior disorders, p -value = .04298, psychotic disorders, p-value = .004274, schizophrenia, p-value = .000141) as well as significant differences among psychiatric parameters: perception (legal highs, opiates), attention (cannabis), consciousness (legal highs), thinking (legal highs), and, instinctive life (legal highs). Conclusions. Personality and behavioral disorders have been particularly linked to opiate use, the psychotic disorder was related to cannabis and legal highs intake, while schizophrenia was related to legal highs intake.
引用
收藏
页码:255 / 265
页数:13
相关论文
共 67 条
[21]   "Spice" and "K2" Herbal Highs: A Case Series and Systematic Review of the Clinical Effects and Biopsychosocial Implications of Synthetic Cannabinoid Use in Humans [J].
Gunderson, Erik W. ;
Haughey, Heather M. ;
Ait-Daoud, Nassima ;
Joshi, Amruta S. ;
Hart, Carl L. .
AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (04) :320-326
[22]   Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine [J].
Harro, Jaanus .
NEUROPSYCHIATRIC COMPLICATIONS OF STIMULANT ABUSE, 2015, 120 :179-204
[23]   Long-term cannabis use and preparedness for ageing [J].
Hasin, Deborah .
LANCET HEALTHY LONGEVITY, 2022, 3 (10) :E645-E646
[24]   Amphetamine, past and present - a pharmacological and clinical perspective [J].
Heal, David J. ;
Smith, Sharon L. ;
Gosden, Jane ;
Nutt, David J. .
JOURNAL OF PSYCHOPHARMACOLOGY, 2013, 27 (06) :479-496
[25]   Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA [J].
Hermanns-Clausen, Maren ;
Mueller, Dieter ;
Kithinji, Josephine ;
Angerer, Verena ;
Franz, Florian ;
Eyer, Florian ;
Neurath, Hartmud ;
Liebetrau, Gesine ;
Auwaerter, Volker .
CLINICAL TOXICOLOGY, 2018, 56 (06) :404-411
[26]  
Hosztafi Sandor, 2011, Acta Pharm Hung, V81, P173
[27]   Benzodiazepines [J].
Howard, Paul ;
Twycross, Robert ;
Shuster, John ;
Mihalyo, Mary ;
Wilcock, Andrew .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (05) :955-964
[28]  
HOWLETT AC, 1988, MOL PHARMACOL, V33, P297
[29]   International Union of Pharmacology. XXVII. Classification of cannabinoid receptors [J].
Howlett, AC ;
Barth, F ;
Bonner, TI ;
Cabral, G ;
Casellas, P ;
Devane, WA ;
Felder, CC ;
Herkenham, M ;
Mackie, K ;
Martin, BR ;
Mechoulam, R ;
Pertwee, RG .
PHARMACOLOGICAL REVIEWS, 2002, 54 (02) :161-202
[30]  
Inanc IH, 2020, J CLIN INVESTIG SURG, V5, P43, DOI [10.25083/2559.5555/5.1/43.50, DOI 10.25083/2559.5555/5.1/43.50]